PEMA Trademark

Trademark Overview


On Friday, February 28, 2025, a trademark application was filed for PEMA with the United States Patent and Trademark Office. The USPTO has given the PEMA trademark a serial number of 79420761. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, June 13, 2025. The PEMA trademark is filed in the Medical Instrument Products category with the following description:

Magnets for therapeutic use; devices for generating magnetic fields for therapeutic treatments; surgical, medical, dental and veterinary apparatus and instruments.
pema

General Information


Serial Number79420761
Word MarkPEMA
Filing DateFriday, February 28, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateFriday, June 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMagnets for therapeutic use; devices for generating magnetic fields for therapeutic treatments; surgical, medical, dental and veterinary apparatus and instruments.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressLI

Trademark Events


Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, April 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 8, 2025APPLICATION FILING RECEIPT MAILED
Friday, June 13, 2025ASSIGNED TO EXAMINER
Friday, June 13, 2025NON-FINAL ACTION WRITTEN
Saturday, June 14, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW